Hematogenous metastases of the human brain - Characteristics of peritumoral brain changes: A review

Journal of Neuro-Oncology

Volumn 35, Issue 1, 1997, Pages 81-89

  Zhang, Mei ^a   Olsson, Yngve ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

amyloid precursor protein; Brain metastases; Endothelin; Glucose transporter; Microglial cells; Reactive astrocytes

Indexed keywords

AMYLOID BETA PROTEIN; ENDOTHELIN; GLUCOSE TRANSPORTER; MYELIN;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN METASTASIS; BRAIN MICROCIRCULATION; HUMAN; MICROGLIA; NEUROPATHOLOGY; OLIGODENDROGLIA;

AXONS; BRAIN; BRAIN EDEMA; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; NEOPLASM CIRCULATING CELLS; NEURONS;

EID: 0030795230     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005799805335     Document Type: Article

References (79)

1. Fried BM, Buckley RC: Primary carcinoma of the lungs. Arch Pathol 9: 483-527, 1930
2. Delattre JY, Krol G, Thaler HT, Posner JB: Distribution of brain metastases. Arch Neurol 45: 741-744, 1988
3. O'Neill BP, Dinapoli RP, Okazaki H: Cerebral infarction as a result of tumor emboli. Cancer 60: 90-95, 1987
4. Willis RA : The Spread of Tumours of the Human Body. Butterworths, London, 1973
5. O'Neill BP, Buckner JC, Coffet RJ, Dinapoli RP, Shaw EG: Brain metastatic lesions. Mayo Clin Proc 69: 1062-1068, 1994
6. Modic M, Beale S: Magnetic resonance imaging of supratentorial neoplasms. In: Wilkins R, Rengachary S (eds) Neurosurgery Update I: Diagnosis, Operative Technique, and Neuro-Oncology. McGraw-Hill, New York 12-29, 1990
7. Rozental JM: Positron emission tomography (PET) and single photon emission computed tomography (SPECT) of brain tumors. Neurol Clin 9: 287-305, 1991
8. Hirsch FR, Paulson OB, Hansen HH, Vraa-Jensen J: Intracranial metastases in small cell carcinoma of the lung. Correlation of clinical and autopsy findings. Cancer 50: 2433-2437, 1982
9. Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System. Edward Arnold, London, 1989
10. Zülch KJ: Brain Tumors. Springer, Berlin, 1986
11. Tomlinson E: Theory and practice of site-specific drug delivery. Adv Drug Del Rev 1: 187-198, 1987
12. Johansson BB: The physiology of the blood-brain barrier. Adv Exp Med Biol 274: 25-39, 1990
13. Gregoire N: The blood-brain barrier. J Neuroradiol 16(3): 238-250, 1989
14. Pardridge WM, Oldendorf WH, Cancilla P, Frank HJ: Blood-brain barrier: Interface between internal medicine and the brain clinical conference. Ann Intern Med 105(1): 82-95, 1986
15. Iannotti F, Fieschi C, Alfano B, Picozzi P, Mansi L, Pozzilli C, Punzo A, Vecchio GD, Lenzi GL, Salvatore M: Simplified, noninvasive PET measurement of blood-brain barrier permeability. J Comput Assist Tomogr 11(3): 390-397, 1987
16. Front D, Israel O, Kohn S, Nir I: The blood-tissue barrier of human brain tumors: correlation of scintigraphic and ultrastructural findings (concise communication). J Nucl Med 25 (4): 461-465, 1984
17. Kohn S, Front D, Nir I: Blood-brain barrier permeability of human gliomas as determined by quantitation of cytoplasmic vesicles of the capillary endothelium and scintigraphic findings. Cancer Invest 7(4): 313-321, 1989
18. Nir I, Levanon D, Iosilevsky G: Permeability of blood vessels in experimental gliomas: Uptake of 99Tc-glucoheptonate and alteration in blood-brain barrier as determined by cytochemistry and electron microscopy. Neurosurgery 25 (4): 523-532, 1989
19. Coomber BL, Stewart PA, Hayakawa K, Farrell CL, Maestro RFD: Quantitative morphology of human glioblastoma multiform microvessels: structural basis of blood-brain barrier defect. J Neurooncol 5(4): 299-307, 1987
20. Vriesendorp FJ, Peagram C, Bigner DD, Groothuis DR: Concurrent measurements of blood flow and transcapillary transport in xenotransplanted human gliomas in immunosuppressed rats. J Natl Cancer Inst 79(1): 123-130, 1987
21. Debbage PL, Gabius HJ, Bise K, Marguth F: Cellular glycoconjugates and their potential endogenous receptors in the cerebral microvasculature of man: A glycohistochemical study. Eur J Cell Biol 46(3): 425-434, 1988
22. Stewart PA, Hayakawa K, Farrell CL, Maestro RFD: Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect. J Neurosurg 67(5): 697-705, 1987
23. Zagzag D, Goldenberg M, Brem S: Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: A n experimental study in a rabbit brain-tumor model. AJR 153(1): 141-146, 1989
24. Yoshimine T, Ushio Y, Hayakawa T, Moto OT, Maruno M, Mogami H: Growth activity of tumors at different intracranial structures: Immunohistochemical study with bromode-oxyuridine. Acta Neuropathol (Berl) 71: 15-18, 1986
25. Ballinger WEJ, Schimpff RD: An experimental model for cerebral metastasis: Preliminary light and ultrastructural studies. J Neuropathol Exp Neurol 38: 19-34, 1979
26. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GM: Brain metabolism during fasting. J Clin Invest 46: 1589-1595, 1967
27. Buschiazzo PM, Terrell EB, Regen DM: Sugar transport across the blood-brain barrier. Am J Physiol 219: 1505-1513, 1970
28. Pardridge WM: Brain metabolism: A perspective from the blood-brain barrier. Physiol Rev 63: 1481-1535, 1983
29. Kalaria RN, Gravina SA, Schmidley JW, Perry G, Harik SI: The glucose transporter of the human brain and blood-brain barrier. Ann Neurol 24: 757-764, 1988
30. Gerhart D, LeVasseur R, Broderius M, Drewes L: Glucose transporter localization in brain using light and electron immunocytochemistry. J Neurosci Res 22: 464-472, 1989
31. Pardridge W, Boado R, Farrell C: Brain-type glucose transporter (glut 1) is selectively localized to the blood-brain barrier: Studies with quantitative western blotting and in situ hybridization. J Biol Chem 265: 18035-18040, 1990
32. Harik S, Kalaria R, Andersson L, Lundahl P, Perry G: Immunocytochemical localization of the erythroid glucose transporter: Abundance in tissues with barrier functions. J Neurosci 10: 3862-3872, 1990
33. Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H: Erythrocyte/HepG2-type glucose transporter is concentrated in cell of blood-tissue barriers. Biochem Biophys Res Commun 173: 67-73, 1990
34. Guerin C, Laterra J, Hruban R, Brem H, Drewes L, Goldstein G: The glucose transporter and blood-brain barrier of human brain tumors. Ann Neurol 28: 758-765, 1990
35. Guerin C, Laterra J, Drewes L, Brem H, Goldstein G: Vascular expression of glucose transporter in experimental brain neoplasms. Am J Pathol 140: 417-425, 1992
36. Harik S, Roessman U: The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors. Ann Neurol 29: 487-491, 1991
37. Zhang M, Olsson Y: Vascular expression of glucose transporter in and around hematogenous metastases of the human brain. Immunohistochemical observations. APMIS 104: 293-301, 1996
38. Neubürger K, Singer L: Über reaktive Veränderungen in der Umgebung carcinomatöser und sarkomatöser Hirntumoren. Virsch Arch 255: 555-579, 1925
39. Henschen F: Tumoren des Zentralnerven systems und seiner Hüllen. In: Lubarsch O, Henke F, Rössle R (eds) Handbuch der Speziellen Patologischen Anatomie und Histologie. Springer Verlag, Berlin 413-665, 1955
40. Willis RA: Secondary tumors. In: Minckler J (ed) Pathology of the Nervous System. McGraw-Hill, New York pp 2178, 1971
41. Zhang M, Olsson Y: β-Amyloid precursor protein accumulates in axon around hematogenous metastases of the human brain. Immunohistochemical observations. Clinical Neuropathology 15: 74-78, 1996
42. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyruther K, Fischer P, Masters CL, Price DL: Precursor of amyloid protein in Alzheimer's disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 87: 1561-1565, 1990
43. Sherriff FE, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S: Markers of axonal injury in post mortem human brain. Acta Neuropathol 88: 433-440, 1994
44. Sherriff FE, Bridges LR, Sivaloganathan S: Early detection of axonal injury after human head trauma using immunocytochemistry for β-amyloid precursor protein. Acta Neuropathol 87: 55-62, 1994
45. Cochran E, Bacci B, Chen Y, Patton A, Gambetti P, Autilio-Gambetti L: Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. Am J Pathol 139: 485-489, 1991
46. Ohgami T, Kitamoto T, Tateishi J: Alzheimer's amyloid precursor protein accumulates within axonal swellings in human brain lesions. Neurosci Lett 136: 75-78, 1992
47. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW: β-Amyloid precursor protein (βA PP) as a marker for axonal injury after head injury. Neurosci Lett 160: 139-144, 1993
48. Lewén A, Li GL, Nilsson P, Olsson Y, Hillered L: Mild focal cerebral trauma produces local and remote changes of A PP-immunoreactivity. NeuroReport 6: 357-360, 1995
49. Povlishock JT: Traumatically induced axonal injury: Pathogenesis and pathobiological implications. Brain Pathol 2: 1-12, 1992
50. Yaghmai A, Povlishock J: Traumatically induced reactive change as visualized through the use of monoclonal antibodies targeted to neurofilament subunits. J Neuropathol Exp Neurol 51: 158-176, 1992
51. Pfeiffer SE, Betschart B, Cook J, Mancini P, Morris R: Glial cell. In: Fedoroff S, Hertz L (eds) Cell, Tissue and Organ Cultures in Neurobiology. Academic Press, New York 287-346, 1977
52. Duffy PE: Astrocytes: Normal, Reactive and Neoplastic. Raven Press, New York, 1983
53. Korbsch H: Über die paralyseähnliche Verlaufsart des Tumor cerebri. Ein Fall von multiplem metastatischen Carcinom. Arch f Psychiatr 72: 165-195, 1924
54. Hilpert P: Über das metastatische Carcinom des Zentralnervensystems. Arch f Psychiatrie 77: 93-114, 1926
55. Eng LF, Ghirnikar RS: GFAP and astrogliosis. Brain Pathol 4: 229-237, 1994
56. Nathaniel EJH, Nathaniel DR: Astroglial response to degeneration of dorsal root fibers in adult rat spinal cord. Exp Neurol 54: 60-76, 1977
57. Gray EG, Guillery RW: Synaptic morphology in the normal and degenerating nervous system. Int Rev Cytol 19: 111-182, 1966
58. Cook RD, Wisniewski HM: The role of oligodendroglia and astroglia in Wallerian degeneration of the optic nerve. Brain Res 61: 191-206, 1973
59. Anderson CA, Westrum LE: An electron microscopic study of the normal synaptic relationships and early degenerative andes in the rat olfactory tubercule. Z Zellforsch 127: 462-482, 1972
60. Zhang M, Olsson Y: Reactions of astrocytes and microglial cells around hematogenous metastases of the human brain. Expression of endothelin like immunoreactivity in reactive astrocytes and activation of microglial cells. J Neurol Sci 134: 26-32, 1995
61. Eng LF: Regulation of glial intermediate filaments in astrogliosis. In: Norenberg MD, Hertz L, Schousboe A (eds) The Biochemical Pathology of Astrocytes. Alan Liss, Inc., New York 79-90, 1988
62. Eddleston M, Mucke L: Molecular profile of reactive astrocytes implications for their role in neurologic disease. Neuroscience 54: 15-36, 1993
63. Eng LF: Astrocytic response to injury. Curr Iss Neur Regen Res 1: 247-255, 1988
64. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
65. Miller RC, Pelton JT, Huggins JP: Endothelins-from receptors to medicine. TIPS 14: 54-60, 1993
66. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T: The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863-2867, 1989
67. Supattapone S, Simpson AWM, Ashley CC: Free calcium rise and mitogenesis in glial cells caused by endothelin. Biochemic Biophys Res Comm 165: 1115-1122, 1989
68. MacCumber M, Ross CA, Snyder H: Endothelin in brain: Receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci USA 87: 2359-2363, 1990
69. Giaid A, Gibson SJ, Ibrahim N, Legon S, Bloom S, Yanagisawa M, Masaki T, Varndell I, Polak J: Endothelin 1 an endothelium-derived peptide is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci USA 86: 7634-7638, 1989
70. Giaid A, Gibson SJ, Herrero MT, Gentleman S, Legon S, Yanagisawa M, Masaki T, Ibrahim NBN, Roberts GW, Rossi ML: Topographical localization of endothelin mRNA and peptide immunoreactivity in neurons of the human brain. Histochemistry 95: 303-314, 1991
71. Jiang MH, Hoog A, Ma KC, Nie XJ, Olsson Y, Zhang WW: Endothelin-1-like immunoreactivity is expressed in human reactive astrocytes. Neuroreport 4: 935-937, 1993
72. Nie XJ, Höög A, Jiang MH, Ma KC, Olsson Y, Zhang WW: Endothelin-like immunoreactivity is expressed in reactive astrocytes in cases of cerebral infarcts and lacunes. Eur J Neurol 1: 135-140, 1994
73. Zhang WW, Badonic T, Höög A, Jiang MH, Ma KC, Nie XJ, Olsson Y: Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin-1. J Neurol Sci 122: 90-96, 1994
74. Yamashita K, Kataoka Y, Niwa M, Shigematsu K, Himeno A, Koizumi S, Taniyama K: Increased production of endothelins in the hippocampus of stroke-prone spontaneously hypertensive rats following transient forebrain ischemia: Histochemical evidence. Cel Mol Neurobiol 13: 15-23, 1993
75. Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, Coligan JE, Kehrl JH, Fauci AS: Endothelins, peptides with potent vasoactive properties are produced by human macrophages. J Exp Med 172: 1741-1748, 1990
76. Ehrenreich H, Kehrl JH, Anderson RW, Rieckmann P, Vitkovic L, Coligan JE, Fauci AS: A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res 538: 54-58, 1991
77. Gehrmann J, Kreutzberg GW: Monoclonal antibodies against macrophages/microglia: Immunocytochemical studies of early microglia activation in experimental neuropathology. Clin Neuropath 12: 301-306, 1993
78. Altman J: Microglia emerge from the fog. TINS 17: 47-49, 1994
79. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW: Cytotoxicity of microglia. Glia 7: 111-118, 1993